Arafi P, Devkota S, Williams E, Maesako M, Wolfe M
Elife. 2025; 13.
PMID: 39932776
PMC: 11813224.
DOI: 10.7554/eLife.102274.
Zhao W, Fan Y, Zhao Q, Fan Z, Zhao J, Yu W
Life Med. 2025; 3(1):lnae011.
PMID: 39872397
PMC: 11749594.
DOI: 10.1093/lifemedi/lnae011.
De Cleene N, Schwarzova K, Labrecque S, Cerejo C, Djamshidian A, Seppi K
Front Neurosci. 2025; 18():1505029.
PMID: 39840019
PMC: 11747286.
DOI: 10.3389/fnins.2024.1505029.
Hayden M, Tyagi N
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770582
PMC: 11676759.
DOI: 10.3390/ph17121741.
Chu C, Uruno A, Katsuoka F, Yamamoto M
Antioxidants (Basel). 2025; 13(12.
PMID: 39765857
PMC: 11727090.
DOI: 10.3390/antiox13121529.
Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease.
Carles A, Freyssin A, Guehairia S, Reguero T, Vignes M, Hirbec H
Alzheimers Res Ther. 2025; 17(1):7.
PMID: 39762936
PMC: 11702188.
DOI: 10.1186/s13195-024-01648-9.
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease.
Kielbasa W, Goldsmith P, Donnelly K, Nuthall H, Shcherbinin S, Fleisher A
Alzheimers Dement (N Y). 2025; 10(4):e70020.
PMID: 39748851
PMC: 11694536.
DOI: 10.1002/trc2.70020.
Anti-aging properties of the aminosterols of the dogfish shark.
Barbut D, Perni M, Zasloff M
NPJ Aging. 2024; 10(1):62.
PMID: 39702521
PMC: 11659403.
DOI: 10.1038/s41514-024-00188-8.
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer's disease models.
Yu Y, Chen C, Celardo I, Tan B, Hurcomb J, Leal N
Cell Death Dis. 2024; 15(11):856.
PMID: 39582067
PMC: 11586400.
DOI: 10.1038/s41419-024-07179-3.
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research.
Ibanez L, Liu M, Beric A, Timsina J, Kohlfeld P, Bergmann K
Alzheimers Dement. 2024; 21(2):e14413.
PMID: 39575871
PMC: 11848383.
DOI: 10.1002/alz.14413.
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence.
Aisen P, Bateman R, Crowther D, Cummings J, Dwyer J, Iwatsubo T
Alzheimers Dement. 2024; 21(1):e14342.
PMID: 39535341
PMC: 11772734.
DOI: 10.1002/alz.14342.
Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP/PS1 mouse model of Alzheimer's disease.
Martinez-Drudis L, Berard M, Musiol D, Rivest S, Oueslati A
Heliyon. 2024; 10(20):e39571.
PMID: 39498012
PMC: 11532864.
DOI: 10.1016/j.heliyon.2024.e39571.
Inhibiting mtDNA transcript translation alters Alzheimer's disease-associated biology.
Gabrielli A, Novikova L, Ranjan A, Wang X, Ernst N, Abeykoon D
Alzheimers Dement. 2024; 20(12):8429-8443.
PMID: 39441557
PMC: 11667520.
DOI: 10.1002/alz.14275.
Timing of Alzheimer's disease biomarker progressions: A two-decade observational study from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Schaap T, Thropp P, Tosun D
Alzheimers Dement. 2024; 20(12):9060-9067.
PMID: 39428963
PMC: 11667498.
DOI: 10.1002/alz.14306.
Readdressing the Localization of Apolipoprotein E (APOE) in Mitochondria-Associated Endoplasmic Reticulum (ER) Membranes (MAMs): An Investigation of the Hepatic Protein-Protein Interactions of APOE with the Mitochondrial Proteins Lon Protease....
Rueter J, Rimbach G, Bilke S, Tholey A, Huebbe P
Int J Mol Sci. 2024; 25(19).
PMID: 39408926
PMC: 11476584.
DOI: 10.3390/ijms251910597.
Clinical application of sparse canonical correlation analysis to detect genetic associations with cortical thickness in Alzheimer's disease.
Kim B, Seo S, Park Y, Kim J, Kim H, Jang H
Front Neurosci. 2024; 18:1428900.
PMID: 39381682
PMC: 11458562.
DOI: 10.3389/fnins.2024.1428900.
Conformational Enigma of TDP-43 Misfolding in Neurodegenerative Disorders.
Pillai M, Jha S
ACS Omega. 2024; 9(39):40286-40297.
PMID: 39372031
PMC: 11447851.
DOI: 10.1021/acsomega.4c04119.
In 2024, the still remains a working hypothesis, no less but certainly no more.
Behl C
Front Aging Neurosci. 2024; 16:1459224.
PMID: 39295642
PMC: 11408168.
DOI: 10.3389/fnagi.2024.1459224.
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production.
Arafi P, Devkota S, Williams E, Maesako M, Wolfe M
bioRxiv. 2024; .
PMID: 39257787
PMC: 11383658.
DOI: 10.1101/2024.08.30.610520.
The Unexpected Role of the Endothelial Nitric Oxide Synthase at the Neurovascular Unit: Beyond the Regulation of Cerebral Blood Flow.
Scarpellino G, Brunetti V, Berra-Romani R, De Sarro G, Guerra G, Soda T
Int J Mol Sci. 2024; 25(16).
PMID: 39201757
PMC: 11354477.
DOI: 10.3390/ijms25169071.
